Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A concise primer on initial crypto choices, risk awareness, and how to approach your first investment with clarity.
19,614 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
In a crowded AI market, committing to a single stock for the rest of 2026 can feel risky. This guide shows a practica...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Brady Corporation has captured market attention with a rapid rally. Learn what’s driving shares brady corporation soa...
Prices rose again in April as energy costs jumped, keeping inflation on households' radar. The latest CPI data show b...
A North American software company that pays users for scrolling has surged to the top of Deloitte’s fastest-growing l...
Ooma stock is catching the eye of traders and long-term investors alike. Here's a clear look at the drivers, the numb...
As tech’s power demand surges, data centers are becoming a bigger profit driver for utilities, prompting fresh debate...
Two popular aerospace ETFs, XAR and ITA, offer different paths to exposure in a sector shaped by defense spending and...
As AI accelerates, the question for investors is clear: will Verisk's valuable data keep its edge or fade into a sea ...